SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death

Neurobiology of Aging

Volumn 33, Issue 6, 2012, Pages 1110-1120

  Seo, Jae Suk ^a   Moon, Myung Hee ^a   Jeong, Jae Kyo ^a   Seol, Jae Won ^a   Lee, You Jin ^a   Park, Byung Hyun ^a   Park, Sang Youel ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Neuronal apoptosis; Neuroprotection; Prion disease; PrP (106 126); Resveratrol; SIRT1

Indexed keywords

CASPASE 3; PRION PROTEIN; PROTEIN BCL XL; PROTEIN P53; RESVERATROL; SIRTUIN 1; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL METABOLISM; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEACETYLATION; DNA FRAGMENTATION; DRUG EFFICACY; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NEUROBLASTOMA; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HEK293 CELLS; HISTONE DEACETYLASES; HUMANS; MICE; NEURONS; PEPTIDE FRAGMENTS; PRIONS; SIRTUIN 1; STILBENES;

EID: 84859480382     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.09.019     Document Type: Article

References (35)

1. Bai Y., Li Q., Yang J., Zhou X., Yin X., Zhao D. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells. Neurosci. Res 2008, 62:9-14.
2. Blander G., Guarente L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem 2004, 73:417-435.
3. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., Hu L.S., Cheng H.L., Jedrychowski M.P., Gygi S.P., Sinclair D.A., Alt F.W., Greenberg M.E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303:2011-2015.
4. Chaudhari A.A., Seol J.W., Lee Y.J., Seol D.W., Park S.Y. Hypoxia protects articular chondrocytes from thapsigargin-induced apoptosis. Biochem. Biophys. Res. Commun 2009, 381:513-517.
5. Corsaro A., Thellung S., Villa V., Principe D.R., Paludi D., Arena S., Millo E., Schettini D., Damonte G., Aceto A., Schettini G., Florio T. Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation. Ann. N. Y. Acad. Sci 2003, 1010:610-622.
6. Das D.K., Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol. Interv 2006, 6:36-47.
7. Donnelly L.E., Newton R., Kennedy G.E., Fenwick P.S., Leung R.H., Ito K., Russell R.E., Barnes P.J. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am. J. Physiol. Lung Cell. Mol. Physiol 2004, 287:L774-L783.
8. Ferreiro E., Costa R., Marques S., Cardoso S.M., Oliveira C.R., Pereira C.M. Involvement of mitochondria in endoplasmic reticulum stress-induced apoptotic cell death pathway triggered by the prion peptide PrP(106-126). J. Neurochem 2008, 104:766-776.
9. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., Tagliavini F. Neurotoxicity of a prion protein fragment. Nature 1993, 362:543-546.
10. Forloni G., Bugiani O., Tagliavini F., Salmona M. Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. Mol. Chem. Neuropathol 1996, 28:163-171.
11. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
12. Jin F., Wu Q., Lu Y.F., Gong Q.H., Shi J.S. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur. J. Pharmacol 2008, 600:78-82.
13. Kaeberlein M., McDonagh T., Heltweg B., Hixon J., Westman E.A., Caldwell S.D., Napper A., Curtis R., DiStefano P.S., Fields S., Bedalov A., Kennedy B.K. Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem 2005, 280:17038-17045.
14. Karuppagounder S.S., Pinto J.T., Xu H., Chen H.L., Beal M.F., Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int 2009, 54:111-118.
15. Kim E.J., Kho J.H., Kang M.R., Um S.J. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol. Cell 2007, 28:277-290.
16. Knutson M.D., Leeuwenburgh C. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr. Rev 2008, 66:591-596.
17. Kretzschmar H.A. Neuropathology of human prion diseases (spongiform encephalopathies). Dev. Biol. Stand 1993, 80:71-90.
18. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
19. Lee J.H., Song M.Y., Song E.K., Kim E.K., Moon W.S., Han M.K., Park J.W., Kwon K.B., Park B.H. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009, 58:344-351.
20. Lee K.J., Panzera A., Rogawski D., Greene L.E., Eisenberg E. Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation. J. Cell Sci 2007, 120:2663-2671.
21. Lo R.Y., Shyu W.C., Lin S.Z., Wang H.J., Chen S.S., Li H. New molecular insights into cellular survival and stress responses: neuroprotective role of cellular prion protein (PrPC). Mol. Neurobiol 2007, 35:236-244.
22. Long J., Gao H., SunL, Liu J., Zhao-Wilson X. Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson's disease model. Rejuvenation Res 2009, 12:321-331.
23. Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001, 107:137-148.
24. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216:136-144.
25. Prusiner S.B. Molecular biology of prion diseases. Science 1991, 252:1515-1522.
26. Prusiner S.B. Prion encephalopathies of animals and humans. Dev. Biol. Stand 1993, 80:31-44.
27. Ray P.S., Maulik G., Cordis G.A., Bertelli A.A., Bertelli A., Das D.K. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic. Biol. Med 1999, 27:160-169.
28. Sadruddin S., Arora R. Resveratrol: biologic and therapeutic implications. J. Cardiometab. Syndr 2009, 4:102-106.
29. Selvaggini C., De Gioia L., Cantu L., Ghibaudi E., Diomede L., Passerini F., Forloni G., Bugiani O., Tagliavini F., Salmona M. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun 1993, 194:1380-1386.
30. Singh N., Gu Y., Bose S., Kalepu S., Mishra R.S., Verghese S. Prion peptide 106-126 as a model for prion replication and neurotoxicity. Front. Biosci 2002, 7:a60-a71.
31. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come? And gone?. Clin. Biochem 1997, 30:91-113.
32. Tang B.L., Chua C.E. SIRT1 and neuronal diseases. Mol. Aspects Med 2008, 29:187-200.
33. Thellung S., Villa V., Corsaro A., Arena S., Millo E., Damonte G., Benatti U., Tagliavini F., Florio T., Schettini G. p38 MAP kinase mediates the cell death induced by PrP106-126 in the SH-SY5Y neuroblastoma cells. Neurobiol. Dis 2002, 9:69-81.
34. Tredici G., Miloso M., Nicolini G., Galbiati S., Cavaletti G., Bertelli A. Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant?. Drugs Exp. Clin. Res 1999, 25:99-103.
35. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., Mayo M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004, 23:2369-2380.